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Abstract A new system for bax-expression in yeast has been
devised to investigate bax’s effect under fermentative and
respiro-fermentative conditions. This has allowed us to show
unambiguously that the ability of bax to kill yeast is higher under
respiratory conditions than under purely fermentative conditions.
The extent of killing under respiro-fermentative conditions (non-
repressive sugars) is intermediate. It has been proposed that the
two proteins adenine nucleotides carrier (ANC) and cytochrome
c play a crucial role in bax-induced cell death. We have
investigated the effects of deletion of the genes encoding the two
proteins on the toxicity induced by bax, using this new system.
The absence of ANC did not modify bax-induced lethality in any
way. Moreover, the absence of cytochrome c also did not prevent
bax-induced death. Only the kinetics of lethality were altered.
All these effects are prevented by co-expression of bcl-xL.
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1. Introduction
Expression of proteins of the bcl-2 family, namely the pro-
apoptotic protein bax, in the budding yeast Saccharomyces
cerevisiae has been used by several groups to study the mo-
lecular mechanisms of action of these proteins [1^5]. Since
yeast does not support any spontaneous apoptotic form of
death, it represents a neutral background that could permit
observations of molecular events that lead to bax-induced
cellular death, independent of the complex regulation network
present in mammalian cells. Yeast has been used to study the
protective e¡ect of anti-apoptotic proteins bcl-2/bcl-xL on
bax-mediated toxicity [2^4], the death phenomena caused by
superoxide-dismutase inactivation independent on bax and the
loss of viability in the stationary phase [6]. More recently,
attempts to study the molecular e¡ects of caspases in yeast
have also been published [7,8].
The fact that bax-expression leads to death of yeast cells is
now well-documented. One interesting aspect of bax-expres-
sion in yeast is that, as in mammalian cells that undergo
apoptosis [9,10], several proteins are relocated from the mito-
chondrial intermembrane space to the cytosol. One of these
proteins is cytochrome c [4], a soluble component of the mi-
tochondrial electron transport chain.
Both the mechanism and the function of this relocalization
remain unclear. It has been demonstrated that exogenous cy-
tochrome c was able to switch-on activation of caspases both
in vivo [11,12] and in vitro [13]. However, several authors
have reported observations of apoptotic cell death where cy-
tochrome c was not relocalized [14]. This may support the
idea that, depending on the cell type and/or apoptotic stim-
ulus, cytochrome c relocalization may or may not be involved
in cell death. In addition, it has to be noted that the universal-
ity of the model involving opening of the permeability tran-
sition pore (PTP) in cytochrome c relocalization has been
doubted by a number of observations: (a) delay between cy-
tochrome c release and PTP-opening in apoptotic cells [15,16],
(b) in vitro experiments showing possibilities of cytochrome c
release without PTP-opening [17,18], (c) PTP-opening without
cytochrome c release [19] and (d) total absence of any perme-
ability transition following bax-expression in yeast [20]. More-
over, recent experiments have shown that in vitro activation
of caspases following PTP-opening by atractyloside treatment
of the mitochondria fraction could be explained by release of
a peroxysomal protease, cathepsin B [21], which is inhibited
by speci¢c caspase inhibitors [22]. It appears to be more and
more obvious that, depending on the apoptotic model, mito-
chondria may or may not be involved in the early steps of
apoptosis. Bax-expressing yeasts could therefore be compared
to several mammalian models where permeability transition
appears to be a consequence, not a cause, of cytochrome c
release and caspase activation, an idea supported by the fact
that activated caspases are able to open PTP and can thus
amplify the initial apoptotic signal [23].
Yeast is able to grow both under respiratory and fermenta-
tive conditions, making it a unique tool to assay the func-
tional involvement of mitochondria in bax-e¡ects. It has
been shown that rho0 yeast cells are less sensitive to bax-in-
duced death [3]. Unfortunately, the GAL10-driven expression
system, which has been used by a number of groups, including
ours, is somewhat di⁄cult to manipulate under fermentative
conditions since the GAL10 promoter is strongly repressed by
glucose. In addition, a number of respiratory-de¢cient yeast
mutants grow badly with galactose as a carbon source, mak-
ing ‘glucose to galactose’ shift experiments hardly interpret-
able. Thus, a number of experiments that emphasize the in-
volvement of mitochondrial protein in bax-e¡ects merely on
the basis of resistance to bax-expression, under fermentative
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conditions, must be carefully evaluated to ensure that no side-
e¡ects explain the results. In this context, elucidation of the
role of the F0F1-ATPase subunits [24] and the adenine nucleo-
tides carrier (ANC) [25] seems to be particularly important.
In this paper, we developed a new system for expressing bax
and bcl-xL in yeast, based on the bacterial tetracyclin-re-
pressed promoter (tetracyclin-o¡ system [26]). This system is
insensitive to the nature of the carbon source present in cul-
ture media, making it a powerful tool to assay the dependence
of bax-e¡ects on di¡erent carbon sources (respiratory or fer-
mentative) and also to test bax-sensitivity of speci¢c respira-
tory-de¢cient mutants. For example, a direct involvement of
PTP in bax-e¡ects can be tested by expressing bax in yeast
strains inactivated for putative PTP components. We have
previously shown that the outer membrane voltage-dependent
anion channel (VDAC) was not involved in bax-mediated
e¡ects, including relocalization of cytochrome c [20]. Here,
we have tested the involvement of the other putative major
component of PTP, the inner-membrane ANC.
Finally, we were able to assay the e¡ect of bax-expression
and bax/bcl-xL co-expression on the growth and death of a
cytochrome c-less yeast strain to test the actual involvement of
cytochrome c in bax-induced yeast cell death.
2. Materials and methods
2.1. Expression plasmids
The human bax gene, chemically synthesized with yeast codon bias,
encodes the K-isoform of the protein [3] and was placed under the
control of a tetracyclin-regulatable promoter (Enrique Herrerro, Llei-
da University, Lleida, Spain) as follows: the bax gene, fused to a
fragment containing the SUC2 transcription terminator with a 5P-
DNA sequence encoding the c-myc epitope EQKLOSEEDLNG,
was isolated from a pSK+ plasmid as a BglII-PvuII fragment and
was then subcloned in centromeric plasmids carrying the tetR repress-
or and the tetO operator sequences [26]. Insertion was done between
the HpaI and BamHI sites of pCM189 (carrying URA3 as yeast se-
lection marker) or between the StuI and BamHI sites of pCM184
(carrying TRP1 as yeast selection marker).
The human bcl-xL gene was subcloned under the control of a tet-
racyclin-regulatable promoter in two steps: the bcl-xL-expression cas-
sette, under the control of the GAL10 promoter, was isolated as a
SacI-SalI fragment from pDP83A described elsewhere [3] and inserted
between the SacI and SalI sites of a pFL39 vector. The Bcl-xL gene
was then isolated from this construct by a MseI digestion and inserted
at the HpaI site of pCM184 [26]. The orientation of the construction
was checked by a HindIII digestion.
2.2. Yeast strains
Strains used are summarized in Table 1. The wild-type W303-1A
strain transformed with pCM189-bax is referred to as WtB1, W303-
1A strain transformed with pCM184-bcl-xL is referred to as WtB3,
W303-1A strain transformed with both pCM189-bax and pCM184-
bcl-xL is referred to as WtB4. Cytochrome c-less strain B-06748 (Da-
vid Pearce, Rochester University, Rochester, USA) was transformed
with pCM189-bax (CtB1 strain) or co-transformed with pCM189-bax
and pCM184-bcl-xL (CtB2 strain). ANC-less JL1-3-1A strain (Jordan
Kolarov, Comenius University, Bratislava, Slovakia) was transformed
with pCM184-bax and is referred to as AtB1. All transformations
were controlled by PCR on yeast colonies.
2.3. Growth conditions and colony forming e⁄ciency
Yeast cells were grown on 0.175% yeast nitrogen base, 0.5% am-
monium sulfate, 0.1% KH2PO4, 0.2% drop mix (a mixture containing
3 g of each auxotrophic marker except adenine, histidine, lysine, leu-
cine, uracil and tryptophan) with addition of the supplements required
for growth of the speci¢c strain (SC-medium). The carbon source was
either 2% glucose (fermentative growth, SC-glucose) or 2% D,L-lactate
(respiratory growth, SC-lactate). In several experiments, other carbon
sources such as 2% glycerol, 1% sucrose, 1% ra⁄nose, 2% mannose or
2% galactose were used (see Section 3). In the presence of 1 Wg/ml
doxycyclin, the tetracyclin-regulatable promoter was repressed. Ex-
pression of genes driven by such a promoter was induced upon anti-
biotic removal [26]. For survival tests, cells were grown in the same
media as above and then spread onto non-selective YPD medium in
the presence of doxycyclin (1% yeast extract, 1% bacto-peptone, 2%
glucose, 10 Wg/ml doxycyclin).
2.4. Protein analysis
Cells were harvested after di¡erent induction times (see Section 3)
and spheroplasts and mitochondria were prepared as described pre-
viously [27,28]. The cytochrome c content was measured by spectro-
photometry on dithionite-reduced versus H2O2-oxidized samples in an
Aminco DW2000 double-beam spectrophotometer. The protein con-
centration was measured with a biuret method.
Bax-expression was analyzed after separating proteins by SDS-
PAGE and blotting onto PVDF membranes (Problott, Applied Bio-
systems). Western analyses were done with a primary anti-c-myc anti-
body (Calbiochem) and a secondary anti-mouse-HRP antibody (Im-
munoPure, Pierce) revealed by enhanced chemio-luminescence (ECL)
(Amersham).
2.5. Electron microscopy
Spheroplasts were ¢xed with 2.5% glutaraldehyde in a 0.1 M so-
dium phosphate bu¡er (pH 7.2) for 4 h at 4‡C, post-¢xed with 1%
osmic acid in the same bu¡er and stained with 2% uranyl acetate.
3. Results and discussion
3.1. Expression of bax and bcl-xL under the control of a
‘tetracyclin-o¡’ system
Bax and bcl-xL were placed under the control of a ‘tetra-
cyclin-o¡’ expression system (see Section 2). With this system,
we were able to induce bax and bcl-xL-expression under fer-
mentative conditions as well as under respiratory conditions
(Fig. 1, top).
Cells were ¢rst grown in liquid medium in the presence of
doxycyclin (expression-repressed) and then spread on glucose
or glycerol-supplemented solid medium in the presence (ex-
pression-repressed) or in the absence (expression-induced) of
doxycyclin. No cell was able to grow both on glycerol and
glucose medium when bax was expressed (data not shown).
The same experiment was done with cells carrying two plas-
Table 1
Yeast strains Genotypes
W303-1B MAT a, ade2, his3, leu2, trpl, ura3
WtB1a MAT a, ade2, his3, leu2, trpl, ura3, pCM189/tetp-bax
(URA3)
WtB3a MAT a, ade2, his3, leu2, trpl, ura3, pCM184/tetp-bcl-
xL (TRP1)
WtB4a MAT a, ade2, his3, leu2, trpl, ura3, pCM189/tetp-bax
(URA3), PCM184/tetp-bcl-xL (TRP1)
B-06748b MAT a, his3, leu2, trpl, ura3, cyh2, cyc1: :lacZ,
cyc7: :CYH2
CtB1a MAT a, his3, leu2, trpl, ura3, cyh2, cyc1: :lacZ,
cyc7: :CYH2, pCM189/tetp-bax (URA3)
CtB2a MAT a, his3, leu2, trpl, ura3, cyh2, cyc1: :lacZ,
cyc7: :CYH2, pCM189/tetp-bax (URA3), pCM184/
tetp-bcl-xL (TRP1)
JL1-3-1Ac MAT a, ade2, trpl, leu2, his3, ura3, anc1: :LEU2,
anc2: :HIS3, anc3: :URA3
AtB1a MAT a, ade2, trpl, leu2, his3, ura3, anc1: :LEU2,
anc2: :HIS3, anc3: :URA3, pCM184/tetp-bax (TRP1)
HT444/baxd MAT a, his4, trp1, lys2, leu2, bax-LEU2
aThis study.
bA gift from David Pearce (Rochester).
cA gift from Jordan Kolarov (Bratislava).
d[3].
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mids, one encoding for bax, the other for bcl-xL, both under
the control of the tetracyclin-o¡ promoter. The proportion of
cells growing on plates upon induction was close to 100% of
the cells growing on plates under repressive conditions, show-
ing that bcl-xL can almost totally rescue bax-mediated e¡ects
in yeast (data not shown, see also below).
In order to allow for further comparisons of the results
obtained with the tetO-driven expression system with those
obtained previously with the GAL10-driven expression system,
we compared the level of expression of bax under the control
of both promoters. Fig. 1 (bottom) is a Western blot analysis
of spheroplast proteins expressing bax under the control of
the two promoters. As reported previously [29], bax expressed
under the control of the GAL10 promoter appears in two
forms: the expected 21 kDa native protein and a shorter
form of about 17 kDa generated from a N-terminal cleavage
of the protein. Western blot analysis of spheroplasts express-
ing bax under the control of the tetO promoter allowed two
conclusions: (i) the total amount of bax (short form+native
form) is markedly lower than with the GAL10 promoter-driv-
en system and (ii) the relative amount of the short form is
much higher than in the GAL10 promoter-driven system. This
result indicated that bax-induced growth arrest was not af-
fected by the N-terminal cleavage of the protein nor by a
lower amount produced in the tetracyclin-o¡ expression sys-
tem.
Fig. 1. Bax-expression. WtB1 cells were grown aerobically under
conditions of bax-expression or absence of expression (see below).
Spheroplasts were prepared, solubilized, 0.25 mg proteins were sepa-
rated by SDS-PAGE, transferred onto PVDF membranes and re-
vealed with a primary anti-c-myc antibody, a secondary anti-mouse
antibody coupled to HRP and revealed by ECL. The upper band
corresponds to native bax at about 21 kDa, the lower band corre-
sponds to 17 kDa [29]. The intermediate band of 18.5 kDa observed
in (bottom, lane E) may be observed only at very high levels of ex-
pression. Top: comparison of tetracyclin promoter-driven expression
in lactate and glucose. Lane A: glucose in the absence of doxycy-
clin, lane B: glucose in the presence of doxycyclin, lane C: lactate
in the presence of doxycyclin, lane D: lactate in the absence of dox-
ycyclin. Bottom: comparison of tetracyclin promoter and GAL10
promoter-driven bax-expression with lactate as a substrate. Lane A:
WtB1 in the presence of doxycyclin, lane B: WtB1 after 4 h in the
absence of doxycyclin, lane C: WtB1 after 12 h in the absence of
doxycyclin, lane D: HT444/bax in complete medium after 3 h in the
presence of galactose, lane E: HT444/bax SC-medium after 3 h in
the presence of galactose.
Fig. 2. Bax-induced growth arrest. WtB1 cells were grown aerobi-
cally in SC-medium supplemented with the indicated sugar, in the
presence of doxycyclin until the early exponential growth phase
(OD550 nm = 1), then harvested, washed twice and resuspended at 0.1
OD550 nm U in the same medium in the absence (open squares) or in
the presence (full squares) of doxycyclin.
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3.2. E¡ect of the carbon source on bax-induced growth arrest
and mortality
From experiments reported previously, bax was as e⁄cient
in inducing growth arrest upon glycerol as upon glucose me-
dia. But these experiments in solid media do not allow us to
draw any conclusion about the kinetics of bax-induced growth
arrest and mortality.
Therefore, cells were grown in liquid medium in the pres-
ence of doxycyclin (no expression) and then inoculated to a
liquid medium without doxycyclin (bax-expression-induced).
At di¡erent time-points, aliquots were taken to measure the
colony forming e⁄ciency (on non-selective doxycyclin-con-
taining plates). This experiment was done in medium supple-
mented with lactate or glucose or sugars which do not induce
a strong catabolic repression of respiratory enzymes (namely
galactose, ra⁄nose, mannose and sucrose).
Fig. 2 depicts the optical density (OD) of cultures after a
shift to medium without doxycyclin with glucose (top) or
mannose (bottom) as substrates. It can be seen that the
growth rate was strongly reduced (although not fully abol-
ished) following the shift. Identical results were obtained
with other carbon sources (lactate, ra⁄nose, sucrose and gal-
actose) (data not shown). This demonstrates that the type of
metabolism (respiratory or fermentative, repressive or not) did
not in£uence bax-induced growth arrest.
Fig. 3 (top) reports the colony forming e⁄ciency of the bax-
expressing wild-type strain WtB1, after a shift to medium
without doxycyclin. A clear di¡erence was evidenced between
lactate and glucose-containing medium. Cell death occurred
rapidly in lactate medium since only 10^15% of the cells were
able to form colonies after a 12 h induction. In contrast, al-
most all cells were viable after a 20 h induction in glucose
medium and about 50% of the cells was still able to form
colonies after a 30 h induction. A 48 h induction was required
to reach a viability level as low as in lactate medium (not
shown). Importantly, with sugars which do not induce catab-
olic repression of respiratory enzymes, such as mannose, cells
were signi¢cantly less resistant to bax-e¡ects than glucose-
grown cells, but remained more resistant than lactate-grown
cells.
From this set of data, it can be concluded that the type of
metabolism did not a¡ect bax-induced growth arrest. This
occurred rapidly both in fermentative medium and in respira-
tory medium. On the contrary, the type of metabolism
strongly a¡ected bax-induced mortality, which ‘follows’
growth arrest under respiratory conditions, but is markedly
delayed under purely fermentative conditions (glucose). Under
respiro-fermentative conditions (other sugars), the situation is
intermediate, suggesting that one or more protein(s) repressed
by glucose are involved in the kinetics of the bax-induced
killing e¡ect.
3.3. Bax-induced growth arrest and lethality in an ANC-less
strain
A major point of discussion about bax-induced cell death in
yeast and, more generally, about the involvement of mito-
chondria in apoptosis is the exact role of the so-called PTP.
On the basis of in vitro experiments, Kroemer and colleagues,
together with other groups, propose that PTP-opening is an
early and crucial step that directly induces cytochrome c re-
lease (and other apoptogenic factors such as apoptosis induc-
ing factor), allowing for further activation of apoptotic path-
ways, namely the caspase cascades [30]. However, other
groups working on in vivo systems did not observe any ob-
vious time correlation between PTP-opening (measured by
mitochondrial vim collapse) and further apoptosis-related
events [15,16,31]. From these contradictory data, it can be
concluded that the involvement of mitochondrial permeability
transition as an early step of apoptosis does not appear to be
as universal as generally considered.
Yeast mitochondria do not have a typical PTP, but they
support an unselective channel (yeast mitochondria unselec-
tive channel) which, although having characteristics distinct
Fig. 3. Bax-induced lethality. Cultures were made in the presence of
glucose (squares), mannose (triangles) or lactate (circles) in the pres-
ence of doxycyclin and then transferred in the same medium in the
absence or in the presence of doxycyclin. At di¡erent times, an ali-
quot of the cultures was taken out and spreaded at 200 cells/plate
on a complete glucose solid medium in the presence of doxycyclin.
The Y-axis is the % of colonies appearing on plates done from the
(3doxycyclin) culture over the number of colonies appearing on
plates done from the (+doxycyclin) culture. Top: WtB1 strain, mid-
dle: AtB1 strain, bottom: CtB1 strain.
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from mammalian PTP, may have similar functions [32]. A
way to evaluate the role of mitochondria permeability transi-
tion was to test the e¡ect of bax in yeast strains inactivated
for putative components of PTP. This has already been done
with the outer membrane VDAC. VDAC-less cells are able to
grow (although slowly) on a respiratory carbon source. The
galactose promoter-driven expression of bax was successfully
used with a clear result: VDAC is not involved in bax-e¡ects
[20].
Such an experiment was not possible with ANC-less strains,
which are impaired for growth on respiratory carbon sources.
An ANC-less strain carrying the tetracyclin promoter-driven
bax-expression system was thus constructed (referred to as
AtB1). The same test of lethality as for the wild-type strain,
comparing glucose and mannose as carbon sources, gave a
clear result : kinetics of bax-induced cell death are not signi¢-
cantly di¡erent for the ANC-less strain and for its wild-type
(Fig. 3, middle).
3.4. Bax-induced lethality in cytochrome c-less strains
In yeast, there are two isoforms of cytochrome c, 1 and 2,
encoded by CYC1 and CYC7 genes, respectively. Under aero-
bic conditions, isoform 1 represents about 95% of the total
amount of the protein. The plasmid encoding bax under the
control of the ‘tetracyclin-o¡’ promoter and carrying the aux-
otrophic marker URA3 was introduced into the vCYC1::lacZ
vCYC7: :CYH2 strain B-06748.
The two tests already described for wild-type and ANC-less
strains were performed. First, cells were grown in liquid glu-
cose medium in the presence of doxycyclin to repress bax-
expression. Cells were then harvested, washed and spread
onto plates containing solid glucose medium without doxycy-
clin, that allows expression of bax (200 cells/plate). Results
were identical for both wild-type and cytochrome c-less
strains: cells were 100% killed following bax-expression
(data not shown). This experiment demonstrates that cyto-
chrome c is not required for bax-induced cell death.
Fig. 4. Electron microscopy (EM) of bax-expressing yeasts. Cells were grown with lactate as a carbon source under non-expressing conditions
and then transferred into the expression medium and spheroplasts were prepared and treated for EM (see Section 2). Typical images of individ-
ual cells are presented. (A) HT444-bax grown in the absence of galactose, (B) Ht444-bax after 3 h in the presence of 0.5% galactose, (C) WtB1
grown in the presence of doxycyclin, (D) WtB1 after 12 h in the absence of doxycyclin. The bar length represents 1 Wm.
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As for the wild-type strain, the second test allowed us to
estimate the kinetics of lethality following bax-expression.
Cells were grown in a liquid medium that contained glucose
or mannose as carbon source and in the presence of doxycy-
clin. After inoculation into a liquid medium without doxycy-
clin, an aliquot of the cultures was taken out at di¡erent time-
points and spread on doxycyclin-containing plates. With glu-
cose as a carbon source, kinetics of bax-induced cell death
were the same for cytochrome c-less strains as for the wild-
type (Fig. 3, bottom). With the non-repressive sugar mannose
as a carbon source, kinetics of bax-induced cell death were
strictly the same as with glucose (Fig. 3). This result di¡ered
markedly from results obtained on wild-type where kinetics of
cell death with mannose (or other non-repressive sugars) were
more rapid than with glucose. From data on wild-type, we
had concluded that one or more glucose-repressed protein(s)
were required for a fast bax-induced cell death. From data on
a cytochrome c-negative strain, it can be concluded that cy-
tochrome c is one of these proteins.
3.5. Bcl-xL-rescuing e¡ect in wild-type and cytochrome c-less
strains
A plasmid encoding bcl-xL under the control of the same
‘tetracyclin-o¡’ promoter and carrying an auxotrophic TRP1
marker was introduced into the wild-type and cytochrome c-
less strains already carrying the ‘tetracyclin-o¡’ plasmid en-
coding bax. Lethality tests were performed exactly as de-
scribed above. For both tests, protection by bcl-xL was total :
100% of the cells were able to grow when plated on a solid
SC-glucose medium without doxycyclin (not shown). This was
an important point to verify, since it shows that bax-induced
cytochrome c-independent death is fully prevented by bcl-xL
co-expression.
3.6. Bax-induced cytochrome c release
We have reported previously that GAL10-driven bax-ex-
pression under respiratory conditions induced a relocalization
of cytochrome c (and other proteins of the mitochondrial
intermembrane space such as adenylate kinase) to the cytosol
[20]. This was also observed in vitro with recombinant bax
that was added to isolated yeast [20] or rat liver [17] mito-
chondria. Under both conditions, at least 50% of cytochrome
c was relocalized from yeast mitochondria.
We therefore looked if the same phenomenon was observed
with tetO-driven bax-expression. Mitochondria were isolated
from cells grown in the presence of doxycyclin (control) or
after di¡erent times of induction. Only a slight decrease of the
amount of cytochrome c was observed both after a 6 or 18 h
induction, in lactate or in glucose medium: whatever the con-
ditions, at least 75% of cytochrome c remained associated to
mitochondria, with an average value around 90% (as com-
pared to 43 þ 7% with GAL10-driven bax-expression). This
result is in accordance with the conclusion coming from the
experiment on the cytochrome c-less strain, that massive cy-
tochrome c relocalization is not absolutely required for bax-
induced cell death.
3.7. Mitochondria morphology
The morphology of bax-expressing cells was assessed by
electron microscopy on spheroplasts. Working on sphero-
plasts instead of intact cells allowed for a better view of the
mitochondria structure in situ. Fig. 4 shows representative
cells observed in di¡erent spheroplast preparations. It is ob-
vious that GAL10-driven expression of bax induces a dramatic
alteration of cells. Mitochondria appear swollen and cristae
cannot be distinguished. It should be noted that mitochondria
isolated from such a preparation still support the permeability
barrier of the inner-membrane but not the permeability bar-
rier of the outer membrane [20]. On the opposite, mitochon-
dria in spheroplasts prepared from tetO-driven bax-expressing
cells do not exhibit any morphological di¡erence compared to
control cells. These results are perfectly consistent with data
related to cytochrome c release.
3.8. Conclusions
A ¢rst important conclusion of this paper is that bax-e¡ects
in yeast di¡er depending on the type of metabolism. Under
respiratory conditions (lactate), there is a strict correlation
between bax-induced growth arrest and death. On the oppo-
site, under fermentative conditions, although growth arrest
occurs within a similar period of time as under respiratory
conditions, bax-induced lethality is markedly delayed. This
di¡erence may be discussed in terms of the cellular vGp.
The intracellular ATP/ADP ratio of yeast may vary from
two under strictly fermentative conditions to above 10 under
respiratory conditions. Since we have already shown that ATP
is required for an optimal e¡ect of bax both in vivo and in
vitro [20], the correlation between both observations seem
obvious: a high ATP/ADP ratio is not necessary for bax-in-
duced growth arrest but is required for a rapid bax-induced
cell death. The second conclusion which can be drawn from
these experiments comes from the di¡erence in kinetics of
bax-induced death in glucose as compared to non-repressive
sugars. This allows us to conclude that at least one glucose-
repressed protein causes the fast kinetics of death.
The second major conclusion of the present paper is that
ANC is not required for bax-induced cell death, under these
conditions. This is a critical point since neither VDAC [20]
nor ANC (this paper), two major putative components of
PTP, are required for bax-induced death and cytochrome c
relocalization. In addition, we demonstrated previously that
bax-induced cytochrome c relocalization occurs in yeast with-
out any obvious permeability transition of the inner mito-
chondrial membrane [20]. Thus, this additional evidence ar-
gues against the involvement of any endogenous
mitochondrial channel for bax-e¡ects in yeast. This conclu-
sion is somewhat contradictory with other reports where
GAL10-driven lexA-bax-expression induced a growth arrest
which was delayed in an ANC-less strain, as compared to a
wild-type [25]. But it must be noted that, as shown in the
present paper, GAL10-driven and tetO-driven bax-expression
yield very di¡erent results concerning cytochrome c relocali-
zation. Moreover, it has already been clearly shown that na-
tive bax has quite di¡erent e¡ects in yeast from the lexA-bax
fusion protein (compare results in [2] and [29,33]).
The third major conclusion is that cytochrome c is neither
strictly required for bax-induced yeast cell death nor for the
protective e¡ect of bcl-xL. However, since kinetics of bax-in-
duced death of a cytochrome c-less strain are the same what-
ever the sugar (glucose or mannose), it can be inferred that
cytochrome c is required for the faster bax-induced death as
observed in wild-type cells grown in non-repressive sugars.
Galactose promoter and tetracyclin promoter-driven bax-
expression systems may represent two di¡erent ways to under-
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stand the molecular e¡ects of bax in yeast. The ¢rst system
gives a massive expression, which induced major alterations of
mitochondrial structures ([2], this paper) (although the inner
mitochondrial membrane remained intact considering its se-
lective permeability [20]), massive cytochrome c relocalization
[4,20] and rapid death [3]. The second system gives a lower
expression, relatively slow death and conservation of the mi-
tochondria structure. This expression system permits the con-
¢rmation of the role of cellular ATP in the kinetics of the
death process. It also highlights a role for cytochrome c : it
is not absolutely required for bax-induced death but its pres-
ence may improve the lethal action of bax in yeast.
Is it possible to understand any aspect of apoptosis form
the yeast model? Recent hypotheses draw a functional rela-
tionship between cytochrome c-induced (or other apoptogenic
mitochondrial proteins-induced) activation of caspases and a
putative ‘amplifying loop’ where these activated proteases are
thought to open PTP and cause an irreversible energetic col-
lapse observed in most apoptotic cells. In this scheme, PTP-
opening and further mitochondrial alterations should be a
consequence, rather than a cause, of caspases activation. Mi-
tochondria might be involved only in a secondary step linked
to over-activation of apoptosis, but not in the primary apop-
totic signal. Our conclusion, as reported above, underlines an
amplifying role of cytochrome c for bax-e¡ects in yeast and is
in accordance with this hypothesis.
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